Paperpal Prime Logo

Minerva Endocrinology : Impact Factor & More

eISSN: 2724-6116pISSN: 2724-6507

Key Metrics

CiteScore
3.7
Impact Factor
< 5
SNIP
0.6
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Minerva Endocrinology

Minerva Endocrinology Journal Specifications

Overview
Publisher EDIZIONI MINERVA MEDICA
Frequency Quarterly
General Details
FrequencyQuarterly
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Minerva Endocrinology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Minerva Endocrinology

Age and tumor size interact to increase the risk of incomplete response to therapy in differentiated thyroid carcinoma.
  • 1 Oct 2026
  • Minerva endocrinology
Hypothalamus-pituitary-adrenocortical responses to critical illness: new insights with clinical implications.
  • 1 Oct 2026
  • Minerva endocrinology
Obesity-cancer convergence in the destiny of an adipocyte.
  • 1 Sep 2026
  • Minerva endocrinology
Amylin role in glucose homeostasis and β-cell function: a robust justification.
  • 1 Sep 2026
  • Minerva endocrinology
Impact of hypoglycemic agents on glycemic control and cognitive decline in older adults with type 2 diabetes: real-world evidence on glucagon like peptide 1 receptor agonists.
  • 1 Sep 2026
  • Minerva endocrinology
Digital platforms influence users and their eating habits.
  • 1 Sep 2026
  • Minerva endocrinology
Age and tumor size interact to increase the risk of incomplete response to therapy in differentiated thyroid carcinoma.
  • 1 Oct 2026
  • Minerva endocrinology
Hypothalamus-pituitary-adrenocortical responses to critical illness: new insights with clinical implications.
  • 1 Oct 2026
  • Minerva endocrinology
Obesity-cancer convergence in the destiny of an adipocyte.
  • 1 Sep 2026
  • Minerva endocrinology
Amylin role in glucose homeostasis and β-cell function: a robust justification.
  • 1 Sep 2026
  • Minerva endocrinology
Impact of hypoglycemic agents on glycemic control and cognitive decline in older adults with type 2 diabetes: real-world evidence on glucagon like peptide 1 receptor agonists.
  • 1 Sep 2026
  • Minerva endocrinology
Digital platforms influence users and their eating habits.
  • 1 Sep 2026
  • Minerva endocrinology

FAQs on Minerva Endocrinology